Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2025 Earnings Call Transcript
Operator: Good morning. Welcome to the Aurinia Pharmaceuticals Third Quarter 2025 Conference Call.
Aurinia Pharmaceuticals Inc. (AUPH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 11,329,500 | $125,190,975 | +13% | 4.82% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,374,021 | $37,282,932 | +214% | 0.02% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,483,132 | $16,388,610 | +1273% | 0.02% |
| 4. | Renaissance Technologies Jim Simons | 1,449,600 | $16,018,080 | +26% | 0.02% |
| 5. | D E Shaw D. E. Shaw | 909,922 | $10,054,638 | +167% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.68 | 200,000 | $2,336,000.00 | 11,329,500 | 2025-08-05 | Filing | |
| $11.34 | 100,000 | $1,134,000.00 | 11,129,500 | 2025-08-04 | Filing | |
| $10.12 | 1,000,000 | $10,120,000.00 | 11,029,500 | 2025-08-01 | Filing | |
| $8.09 | 100,000 | $809,000.00 | 10,029,500 | 2025-03-04 | Filing | |
| $7.92 | 500,000 | $3,960,000.00 | 9,929,500 | 2025-03-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 20,000 | $210,000.00 | 133,484 | 2025-08-01 | Filing | |
| $8.23 | 8,305 | $68,350.15 | 153,484 | 2025-03-07 | Filing | |
| $7.92 | 164,947 | $1,306,380.24 | 1,788,945 | 2025-03-04 | Filing | |
| $8.00 | 195,593 | $1,564,744.00 | 1,953,892 | 2025-03-03 | Filing | |
| $8.00 | 12,239 | $97,912.00 | 161,789 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,448,858 | $82,309,882 | 0% | |
| 2. | 3,969,834 | $43,866,666 | 2.41% | |
| 3. | 2,693,755 | $29,765,993 | 0% | |
| 4. | 1,946,785 | $21,511,978 | 0% | |
| 5. | 1,557,509 | $17,210,474 | 0% |
News See All
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call Transcript July 31, 2025Aurinia Pharmaceuticals Inc. misses on earnings expectations.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Inc. Q1 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript February 27, 2025Aurinia Pharmaceuticals Inc. misses on earnings expectations.
10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2024 Earnings Call Transcript August 1, 2024Aurinia Pharmaceuticals Inc. misses on earnings expectations.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.18.